GRK2 inhibits Flt-1<sup>+</sup> macrophage infiltration and its proangiogenic properties in rheumatoid arthritis.

Authors:
Yang X; Zhao Y; Wei Q; Zhu X; Wang L and 5 more

Journal:
Acta Pharm Sin B

Publication Year: 2023

DOI:
10.1016/j.apsb.2023.09.013

PMCID:
PMC10792976

PMID:
38261818

Journal Information

Full Title: Acta Pharm Sin B

Abbreviation: Acta Pharm Sin B

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest The authors have no conflicts of interest to declare."

Evidence found in paper:

"We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript. We thank all the patients who participated in providing us with synovial tissues and blood samples. Graphical abstract was created with BioRender.com (publication and licensing rights number JZ25ROGTF8). This study was supported by the 10.13039/501100001809National Natural Science Foundation of China (No. 82003763, No. 81973332, No. 82173824, No. 82204405, No. 82204402), Research Fund of Anhui Institute of translational medicine (2022zhyx-B04, China), The 2022 Basic and Clinical Collaborative Research of Anhui Medical University (2022sfy015, China), and Natural Science Foundation of Anhui Provincial (2108085QH383, China)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025